Pei Luo Selected Research

Myocardial Ischemia (Ischemic Heart Diseases)

1/2023	RGD and Scutellarin Conjugate (WK001) Targeting Platelet Glycoprotein IIb/IIIa Receptor Protects from Myocardial Ischemia/Reperfusion Injury: Synthesis, Characterization, and Bioactivity Evaluation.
9/2022	Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine.
1/2020	Astragaloside IV Derivative (LS-102) Alleviated Myocardial Ischemia Reperfusion Injury by Inhibiting Drp1Ser616 Phosphorylation-Mediated Mitochondrial Fission.
9/2017	Synthesis and cardiomyocyte protection activity of crocetin diamide derivatives.
1/2016	Caffeoylquinic Acid Derivatives Extract of Erigeron multiradiatus Alleviated Acute Myocardial Ischemia Reperfusion Injury in Rats through Inhibiting NF-KappaB and JNK Activations.
11/2010	Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pei Luo Research Topics

Disease

15	Neoplasms (Cancer) 10/2023 - 01/2014
13	Inflammation (Inflammations) 05/2024 - 05/2008
8	Hypoxia (Hypoxemia) 01/2022 - 01/2016
7	Reperfusion Injury 01/2023 - 11/2010
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 11/2010
6	Body Weight (Weight, Body) 01/2022 - 01/2018
5	Ischemia 01/2020 - 11/2010
4	Fibrosis (Cirrhosis) 02/2024 - 09/2022
4	Cardiovascular Diseases (Cardiovascular Disease) 07/2023 - 01/2018
4	Edema (Dropsy) 04/2020 - 05/2008
3	Vascular Calcification 01/2023 - 01/2018
3	Myocardial Infarction 01/2023 - 01/2018
3	Obesity 01/2022 - 01/2019
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 07/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 01/2017
2	Infections 05/2024 - 01/2021
2	Wounds and Injuries (Trauma) 11/2023 - 06/2018
2	Metabolic Diseases (Metabolic Disease) 10/2023 - 01/2022
2	Hearing Loss (Hearing Impairment) 08/2023 - 01/2023
2	Insulin Resistance 01/2023 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2017
2	Diabetes Mellitus 01/2023 - 01/2018
2	Chronic Renal Insufficiency 01/2023 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 12/2013
2	Thrombosis (Thrombus) 01/2023 - 01/2022
2	Infarction (Infarctions) 01/2022 - 05/2011
2	Peritonitis 01/2022 - 03/2021
2	COVID-19 01/2021 - 10/2020
2	Arthritis (Polyarthritis) 01/2020 - 10/2017
2	Carcinogenesis 12/2017 - 11/2017
1	Polyps 05/2024
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2024
1	Binge Drinking 02/2024
1	Alcoholism (Alcohol Abuse) 02/2024
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2023
1	Immune System Diseases (Immune Disorders) 10/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2023
1	Colitis 05/2023

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2017
5	CytokinesIBA 01/2022 - 01/2018
4	astragaloside AIBA 10/2023 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2017
4	LS-102IBA 01/2022 - 04/2019
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2024 - 12/2019
3	Interleukin-6 (Interleukin 6)IBA 02/2024 - 01/2018
3	CollagenIBA 02/2024 - 10/2017
3	OligosaccharidesIBA 11/2023 - 03/2021
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 10/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 01/2018
3	Insulin (Novolin)FDA Link 01/2023 - 12/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2008
3	Oxygen (Dioxygen)IBA 01/2021 - 11/2018
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2011
3	CarrageenanIBA 10/2017 - 05/2008
2	Messenger RNA (mRNA)IBA 03/2024 - 04/2018
2	Estrogens (Estrogen)FDA Link 02/2024 - 01/2022
2	Serotonin (5 Hydroxytryptamine)IBA 02/2024 - 12/2010
2	scutellarinIBA 01/2023 - 09/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2022
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 12/2019
2	GoldIBA 01/2022 - 12/2019
2	AntioxidantsIBA 11/2021 - 04/2020
2	LipopolysaccharidesIBA 03/2021 - 01/2018
2	Xylenes (Xylene)IBA 04/2020 - 05/2008
2	Blood Glucose (Blood Sugar)IBA 08/2019 - 12/2013
2	AcidsIBA 04/2019 - 01/2016
2	Durapatite (Hydroxylapatite)IBA 01/2019 - 01/2018
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018 - 05/2011
2	Estrogen ReceptorsIBA 01/2018 - 05/2011
2	NF-kappa B (NF-kB)IBA 01/2016 - 07/2008
2	Nitric Oxide Synthase (NO Synthase)IBA 05/2011 - 11/2010
1	Methotrexate (Mexate)FDA LinkGeneric 05/2024
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2024
1	Sulindac (Copal)FDA LinkGeneric 05/2024
1	Celecoxib (Celebrex)FDA Link 05/2024
1	Ethanol (Ethyl Alcohol)IBA 02/2024
1	SodiumIBA 02/2024
1	CelluloseIBA 11/2023
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 11/2023
1	HydrogelsIBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 10/2023
1	LigandsIBA 10/2023
1	ligustilideIBA 10/2023
1	PTX3 proteinIBA 10/2023
1	KYA1797KIBA 10/2023
1	CateninsIBA 10/2023
1	Peptides (Polypeptides)IBA 08/2023
1	Advanced Glycation End ProductsIBA 07/2023
1	Dextran SulfateIBA 05/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2023
1	CalciumIBA 01/2023

Therapy/Procedure

12	Therapeutics 03/2024 - 12/2013
4	Ligation 01/2020 - 01/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 07/2017 - 01/2017
2	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 09/2008 - 05/2008
1	Complementary Therapies (Alternative Medicine) 03/2024
1	Oral Administration 02/2024
1	Injections 11/2023